Glenmark Pharma Q2 revenue falls 30% to ₹4,247 crore, profit down 57%
Glenmark Pharmaceuticals' Q2FY27 net profit fell 56.8% to ₹263.83 crore, while revenue declined 29.8% to ₹4,247.32 crore, with earnings dragged by exceptional items.
BTC-5.54%
ETH-7.58%
SOL-6.60%
USDC+0.00%
XRP-5.14%
HYPE-7.28%
SUI-9.05%
DOGE-7.20%BTC-5.54%ETH-7.58%SOL-6.60%USDC+0.00%XRP-5.14%HYPE-7.28%SUI-9.05%DOGE-7.20%BTC-5.54%ETH-7.58%SOL-6.60%USDC+0.00%XRP-5.14%HYPE-7.28%SUI-9.05%DOGE-7.20%BTC-5.54%ETH-7.58%SOL-6.60%USDC+0.00%XRP-5.14%HYPE-7.28%SUI-9.05%DOGE-7.20%
